Please login to the form below
virtual
This page shows the latest virtual news and features for those working in and with pharma, biotech and healthcare.
Gilead reports remdesivir cuts risk of death in severe COVID-19 patients
The additional remdesivir data, presented at the Virtual COVID-19 Conference last week, includes new comparative analysis from the phase 3 SIMPLE-Severe trial and a real-world retrospective cohort of ... The data presented at the Virtual COVID-19
Latest news
-
Porter Novelli wins first Best Use of Data Visualisation Award at Communiqué 2020
The winning initiative for this new category was created by Pfizer Oncology. The Porter Novelli team celebrates its win at the virtual awards ceremony. ... The inaugural ‘Best Use of Data Visualisation’ category was won by Porter Novelli for its
-
ENGINE MHP scores Charitable Campaign of the Year Award at Communiqué 2020
Campaign for Alzheimer’s Research UK was the clear winner. The ENGINE MHP team celebrates its win at the virtual awards ceremony. ... ENGINE MHP and Alzheimer’s Research UK picked up the coveted ‘Charitable Campaign of the Year’ Award at the
-
OPEN Health scoops up Medical Affairs Agency Award at Communiqué 2020
Agency proves ongoing expertise in medical affairs at virtual awards. OPEN Health Medical Communications proved once again that the agency’s medical affairs expertise is outstanding, after winning the Publicis Health ... For the first time, due to the
-
Launch leaders’ blog part 1
How do I move my engagement and promotional mix to more virtual/digital activities? ... How do I plan my launch across countries and functions in the virtual environment?
-
WHO takes stock of global COVID-19 R&D progress
Researchers and developers meet virtually to discuss progress. After global deaths caused by COVID-19 topped over half a million, the World Health Organization (WHO) held a virtual summit last week ... Researchers, developers and funders from across the
More from news
Approximately 5 fully matching, plus 190 partially matching documents found.
Latest Intelligence
-
Post-COVID-19 behaviour – the new normal or nothing new?
Many state that while face- to-face meetings with both patients and reps remain valuable, there are also clear benefits to virtual meetings and digital communications in certain circumstances.
-
Persuasive technology: designing behaviour change initiatives for digital
However, creating impactful virtual and online support tools (that are relevant, engaging, credible, trustworthy, timely and easy to use) relies on providers using the right content and technology for digital specific
-
A time of change, a time to change?
Rather than having to travel or submit a written report, specialists are finding virtual meetings a game changer – ensuring that their views are heard, and patients are discussed holistically, while staying ... For pharma, this means redefining the
-
Multichannel engagement and the need for greater understanding of European markets
Now more than ever, reps will be reliant on making use of existing online channels for virtual contact and adopting remote engagement strategies with physicians.
-
Are virtual congresses the new ‘jetpacks’?
Physical vs virtual. Companies, participants and sponsors all want different things from their events. ... The ‘bigger picture’ of how virtual events will evolve remains to be seen.
More from intelligence
Approximately 2 fully matching, plus 72 partially matching documents found.
Latest appointments
-
IGNIFI expands healthcare team with two new hires
Our clients operate in regulated environments and we’re here to help them utilise a wide range of communication techniques, including content marketing and most recently virtual reality, to engage patients,
-
imc, ROAD, Executive Insight and Life Healthcare adds to teams
virtual medical affairs and other services.
-
The Difference Collective boosts its creative and media offerings
Stuart Mayell and Jo Willey join the group. Virtual healthcare specialist The Difference Collective has appointed two of its senior freelance consultants to its core collective team.
-
Concept Life Sciences adds to its scientific and commercial team
Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma.
-
Illumina expands board of directors
He is currently chairman of the board at Microsoft, and served as chief executive officer of IT infrastructure service Virtual Instruments between 2010 and 2016.
More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest from PMHub
-
Virtual Engagement At Porterhouse: Reflections on the past few months
we have found to be the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world. ... In the future, a hybrid of in-person and virtual communication likely offers the most effective and convenient method of
-
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. ... Adopting virtual reality as a tool for participant retention Amazingly, virtual reality (VR) has been shown to reduce pain, anxiety and stress.
-
Valid Insight: TRAVELLESS, the Virtual Workshop Solution for Pharma
Valid Insight’s virtual workshops can provide a cost-and-time effective solution, eliminating the challenges above, without any IT and technology concerns.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
After being inspired by the positivity and resilience we heard in the undiagnosed children’s stories, the emotive team signed up to complete SWAN UK’s Virtual Marathon to raise money
-
Secondary effects of COVID-19 on the healthcare system and patients
We are getting to the point where we need to start considering the long-term effects on the healthcare system when making decisions. By now, your social media feeds are probably full of COVID-19-related news articles, opinion pieces, and memes (not
More from PMHub
Approximately 42 fully matching, plus 148 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Novartis builds its case for novel MS treatment ofatumumab
- New study identifies drugs that are safe to use in COVID-19 treatment
- AbbVie, Amgen and Takeda team up for joint COVID-19 trial
- Novavax reports promising phase 1 results for coronavirus vaccine
- AbbVie exits Voyager alliance for Alzheimer’s/Parkinson’s gene therapies
- Eli Lilly begins COVID-19 prevention trial in nursing homes
- Porterhouse Medical Group joins imc group
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Bristol-Myers Squibb’s revenues rise on Celgene acquisition
- Socially distanced strategising
- Artificial Intelligence in Digital Therapeutics
PMHub
Research Partnership
We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...
Latest intelligence
- Virtual Engagement At Porterhouse: Reflections on the past few months
- A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
- July 2020: diversity and inclusion in clinical trials round-up
- COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
- Medical Device Clinical Trials 2020
- In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...
Quick links
Infographics
